PATHOGENESIS CORP
15-12G, 2000-09-22
PHARMACEUTICAL PREPARATIONS
Previous: STOCKWALK COM GROUP INC, 8-K, EX-99.1, 2000-09-22
Next: INTERNET HOLDINGS INC, DEF 14A, 2000-09-22



<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                     FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTION 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

                                                Commission File Number: 0-27150
                                                                       --------

                            PATHOGENESIS CORPORATION
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

                             201 Elliott Avenue West
                            Seattle, Washington 53214
                                 (206) 467-8100
--------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)

           Common Stock, $.001 par value; and the Associated Preferred
                              Stock Purchase Rights
--------------------------------------------------------------------------------
            (Title of each class of securities covered by this Form)

                                      None
--------------------------------------------------------------------------------
   (Titles of all other classes of securities for which a duty to file reports
                     under section 12(a) or 15(d) remains)

         Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:

<TABLE>

              <S>                                       <C>

                  Rule 12g-4(a)(1)(i)       |X|           Rule 12h-3(b)(1)(i)       |X|
                  Rule 12g-4(a)(1)(ii)      |_|           Rule 12h-3(b)(1)(ii)      |_|
                  Rule 12g-4(a)(2)(i)       |_|           Rule 12h-3(b)(2)(i)       |_|
                  Rule 12g-4(a)(2)(ii)      |_|           Rule 12h-3(b)(2)(ii)      |_|
                                                          Rule 15d-6                |_|

</TABLE>


         Approximate number of holders of record as of the certification or
notice date:   1
            -------

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.

Date:   SEPTEMBER 22, 2000      By: /s/ Alan R. Meyer
       ----------------------      --------------------------------------------
                                     Name:  Alan R. Meyer
                                     Title: Executive Vice President
                                            and Chief Financial Officer



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission